Journal: Journal of Food Science and Technology

Article Title: Functional characterization and microencapsulation of probiotic bacteria from koozh

doi: 10.1007/s13197-015-2169-5

Figure Lengend Snippet: Molecular identification of PLAB and their sequence analog of geographical distribution

Article Snippet: Genotype of probiotic LAB Of the 69 isolates, PPLAB isolates that showed acid tolerance, bile resistance and antibacterial activity were represented as probiotic lactic acid bacteria (PLAB) submitted to Macrogen, Korea for sequencing.

Techniques: Sequencing, Northern Blot

Journal: Journal of Food Science and Technology

Article Title: Functional characterization and microencapsulation of probiotic bacteria from koozh

doi: 10.1007/s13197-015-2169-5

Figure Lengend Snippet: Viability of PLAB isolates before- after freeze drying (FDP) and spray drying (SDP)

Article Snippet: Genotype of probiotic LAB Of the 69 isolates, PPLAB isolates that showed acid tolerance, bile resistance and antibacterial activity were represented as probiotic lactic acid bacteria (PLAB) submitted to Macrogen, Korea for sequencing.

Techniques:

Journal: Current Nutrition Reports

Article Title: Maternal Intake of Probiotics to Program Offspring Health

doi: 10.1007/s13668-022-00429-w

Figure Lengend Snippet: Pre-clinical studies evaluating probiotic administration starting before or during gestation on offspring outcomes

Article Snippet: , SPF C57BL/6 mice ± probiotics Dams n = 10/group Offspring n = 8–10/group/time point (male and female) , Akkermansia muciniphila MucT (ATCC BAA-835) 1 × 10 8 –10 9 CFU/day by gavage GD1–3 days before birth; PND3–PND21 , Until PND42 : No effect on body weight or intestinal tissue development , Dams No effect during pregnancy PND21 : ↑ A. muciniphila , Ruminococcus _1, ↓ Coriobacteriaceae UCG-002, Lachnospiraceae UCG-001, Ruminiclostridium Offspring No effect on A. muciniphila abundance or ⍺-diversity PND42 : Change in β-diversity, ↓ Dubosiella , Lachnospiraceae _UCG_001, Parasutterella , ↑ Gordonibacter , Lachnospiraceae _UCG_006, Prevotellaceae _UCG_001; ↑ the D-glutamine and D-glutamate microbial metabolism pathway , [ ] .

Techniques: Animal Model, Control, Probiotics, Infection, Mouse Assay, Clinical Proteomics, Bacteria, Activity Assay, Expressing, Activation Assay, Concentration Assay, Gene Expression, Permeability, Injection

Journal: Current Nutrition Reports

Article Title: Maternal Intake of Probiotics to Program Offspring Health

doi: 10.1007/s13668-022-00429-w

Figure Lengend Snippet: Clinical studies evaluating probiotic administration starting before and during gestation on offspring outcomes

Article Snippet: , SPF C57BL/6 mice ± probiotics Dams n = 10/group Offspring n = 8–10/group/time point (male and female) , Akkermansia muciniphila MucT (ATCC BAA-835) 1 × 10 8 –10 9 CFU/day by gavage GD1–3 days before birth; PND3–PND21 , Until PND42 : No effect on body weight or intestinal tissue development , Dams No effect during pregnancy PND21 : ↑ A. muciniphila , Ruminococcus _1, ↓ Coriobacteriaceae UCG-002, Lachnospiraceae UCG-001, Ruminiclostridium Offspring No effect on A. muciniphila abundance or ⍺-diversity PND42 : Change in β-diversity, ↓ Dubosiella , Lachnospiraceae _UCG_001, Parasutterella , ↑ Gordonibacter , Lachnospiraceae _UCG_006, Prevotellaceae _UCG_001; ↑ the D-glutamine and D-glutamate microbial metabolism pathway , [ ] .

Techniques: Control, Capsules, Probiotics, Methylation, DNA Methylation Assay, Biomarker Discovery

Journal: Current Nutrition Reports

Article Title: Maternal Intake of Probiotics to Program Offspring Health

doi: 10.1007/s13668-022-00429-w

Figure Lengend Snippet: Offspring health outcomes programmed by maternal probiotic intake started prenatally. Previous knowledge (until 2017) included growth, gut health and intestinal barrier, allergic diseases, and gut microbiota findings. In addition to these outcomes, recent studies described effects on metabolic disorders, and neurodevelopment and anxiety. Clinical and pre-clinical findings are indicated in bold and italics, respectively. Icons depict findings assessed in infants or animal models (mice, rats, rabbits, or pigs). Created with BioRender.com

Article Snippet: , SPF C57BL/6 mice ± probiotics Dams n = 10/group Offspring n = 8–10/group/time point (male and female) , Akkermansia muciniphila MucT (ATCC BAA-835) 1 × 10 8 –10 9 CFU/day by gavage GD1–3 days before birth; PND3–PND21 , Until PND42 : No effect on body weight or intestinal tissue development , Dams No effect during pregnancy PND21 : ↑ A. muciniphila , Ruminococcus _1, ↓ Coriobacteriaceae UCG-002, Lachnospiraceae UCG-001, Ruminiclostridium Offspring No effect on A. muciniphila abundance or ⍺-diversity PND42 : Change in β-diversity, ↓ Dubosiella , Lachnospiraceae _UCG_001, Parasutterella , ↑ Gordonibacter , Lachnospiraceae _UCG_006, Prevotellaceae _UCG_001; ↑ the D-glutamine and D-glutamate microbial metabolism pathway , [ ] .

Techniques:

Journal: International Journal of Molecular Sciences

Article Title: Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature

doi: 10.3390/ijms25053010

Figure Lengend Snippet: Effects of Lactiplantibacillus plantarum , alone or in combination with neurodegenerative diseases (in human and animal model).

Article Snippet: , Lactobacillus plantarum CRL2130, Lactobacillus plantarum CRL725 , 35 neuro-2a (N2a) neuroblastoma cell line (ATCC CCL131) mice , In vitro: Half of each brain was removed for the determination of cytokines; The other half of the brain was stored in 10% paraformaldehyde/PBS during 24 h and then embedded in paraffin; In vivo: Treatment with probiotic vs. Sham , In vitro: N2a cells were incubated with intracellular extract from L. plantarum CRL2130. In vivo: Lactobacillus plantarum CRL2130, Lactobacillus plantarum CRL725 (100 μL) once , In vitro: cells-maintained viability and significantly decreased IL-6 release and reactive oxygen species (ROS) formation. In vivo: attenuated motor deficits and prevented dopaminergic neuronal death , 10.1007/s11064-021-03520-w , [ ] .

Techniques: Control, In Vitro, Capsules, Probiotics, Animal Model, Bacteria, Biomarker Discovery, Isolation, Saline, Modification, Expressing, Produced, In Vivo, Incubation, Suspension, Activation Assay, Formulation, Membrane, Activity Assay